Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

Cell Host and Microbe

Volumn 21, Issue 4, 2017, Pages 530-537.e4

  Segal, Leopoldo N ^a   Clemente, Jose C ^b   Li, Yonghua ^a   Ruan, Chunhai ^c   Cao, Jane ^c   Danckers, Mauricio ^a   Morris, Alison ^e   Tapyrik, Sarah ^f   Wu, Benjamin G ^a   Diaz, Philip ^f   Calligaro, Gregory ^d   Dawson, Rodney ^d   van Zyl Smit, Richard N ^d   Dheda, Keertan ^d   Rom, William N ^a   Weiden, Michael D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

dysbiosis; FoxP1; FoxP3; HIV; lung; short chain fatty acids; tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BUTYRIC ACID; GAMMA INTERFERON; INTERLEUKIN 17; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGEN; PROPIONIC ACID; RNA 16S; UNCLASSIFIED DRUG; ANTIRETROVIRUS AGENT; IL17A PROTEIN, HUMAN; IMMUNOLOGIC FACTOR; VOLATILE FATTY ACID;

ADULT; ANAEROBIC BACTERIUM; ANAEROBIC FERMENTATION; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROBIOME; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PREVOTELLA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICAN; TUBERCULOSIS; BLOOD; COMPLICATION; DISEASE PREDISPOSITION; GROWTH, DEVELOPMENT AND AGING; HIV INFECTIONS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; REGULATORY T LYMPHOCYTE; SECRETION (PROCESS); SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

ANTI-RETROVIRAL AGENTS; BACTERIA, ANAEROBIC; DISEASE SUSCEPTIBILITY; FATTY ACIDS, VOLATILE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; LUNG; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PULMONARY;

EID: 85016474563     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.03.003     Document Type: Article

References (50)

1. Borgdorff, H., Gautam, R., Armstrong, S.D., Xia, D., Ndayisaba, G.F., van Teijlingen, N.H., Geijtenbeek, T.B., Wastling, J.M., van de Wijgert, J.H., Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol. 9 (2016), 621–633.
2. Bourriaud, C., Robins, R.J., Martin, L., Kozlowski, F., Tenailleau, E., Cherbut, C., Michel, C., Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J. Appl. Microbiol. 99 (2005), 201–212.
3. Brenchley, J.M., Paiardini, M., Knox, K.S., Asher, A.I., Cervasi, B., Asher, T.E., Scheinberg, P., Price, D.A., Hage, C.A., Kholi, L.M., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 (2008), 2826–2835.
4. Cailliez, F., The analytical solution of the additive constant problem. Psychometrika 48 (1983), 305–310.
5. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
6. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S.M., Betley, J., Fraser, L., Bauer, M., et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6 (2012), 1621–1624.
7. Churchyard, G.J., Fielding, K.L., Lewis, J.J., Coetzee, L., Corbett, E.L., Godfrey-Faussett, P., Hayes, R.J., Chaisson, R.E., Grant, A.D., Thibela TB Study Team. A trial of mass isoniazid preventive therapy for tuberculosis control. N. Engl. J. Med. 370 (2014), 301–310.
8. Cosgrove, C., Ussher, J.E., Rauch, A., Gärtner, K., Kurioka, A., Hühn, M.H., Adelmann, K., Kang, Y.H., Fergusson, J.R., Simmonds, P., et al. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood 121 (2013), 951–961.
9. Das, B., Dobrowolski, C., Shahir, A.M., Feng, Z., Yu, X., Sha, J., Bissada, N.F., Weinberg, A., Karn, J., Ye, F., Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications. Virology 474 (2015), 65–81.
10. Dillon, S.M., Kibbie, J., Lee, E.J., Guo, K., Santiago, M.L., Austin, G.L., Gianella, S., Landay, A.L., Donovan, A.M., Frank, D.N., et al. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation. AIDS 31 (2017), 511–521.
11. Durek, P., Nordström, K., Gasparoni, G., Salhab, A., Kressler, C., de Almeida, M., Bassler, K., Ulas, T., Schmidt, F., Xiong, J., et al., DEEP Consortium. Epigenomic profiling of human CD4(+) T cells supports a linear differentiation model and highlights molecular regulators of memory development. Immunity 45 (2016), 1148–1161.
12. El Hed, A., Khaitan, A., Kozhaya, L., Manel, N., Daskalakis, D., Borkowsky, W., Valentine, F., Littman, D.R., Unutmaz, D., Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 201 (2010), 843–854.
13. Feng, X., Wang, H., Takata, H., Day, T.J., Willen, J., Hu, H., Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat. Immunol. 12 (2011), 544–550.
14. Fierer, N., Ladau, J., Clemente, J.C., Leff, J.W., Owens, S.M., Pollard, K.S., Knight, R., Gilbert, J.A., McCulley, R.L., Reconstructing the microbial diversity and function of pre-agricultural tallgrass prairie soils in the United States. Science 342 (2013), 621–624.
15. Gao, Z., Tseng, C.H., Pei, Z., Blaser, M.J., Molecular analysis of human forearm superficial skin bacterial biota. Proc. Natl. Acad. Sci. USA 104 (2007), 2927–2932.
16. Gold, M.C., Eid, T., Smyk-Pearson, S., Eberling, Y., Swarbrick, G.M., Langley, S.M., Streeter, P.R., Lewinsohn, D.A., Lewinsohn, D.M., Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol. 6 (2013), 35–44.
17. Gopal, R., Rangel-Moreno, J., Slight, S., Lin, Y., Nawar, H.F., Fallert Junecko, B.A., Reinhart, T.A., Kolls, J., Randall, T.D., Connell, T.D., Khader, S.A., Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 6 (2013), 972–984.
18. Group, T.A.S., Danel, C., Moh, R., Gabillard, D., Badje, A., Le Carrou, J., Ouassa, T., Ouattara, E., Anzian, A., Ntakpe, J.B., et al. A trial of early antiretrovirals and isoniazid preventative therapy in africa. N Engl J Med. 373 (2015), 808–822.
19. Humphries, J., Xiong, L., Liu, J., Prindle, A., Yuan, F., Arjes, H.A., Tsimring, L., Suel, G.M., Species-independent attraction to biofilms through electrical signaling. Cell 168 (2017), 200–209.e212.
20. Imai, K., Ochiai, K., Okamoto, T., Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J. Immunol. 182 (2009), 3688–3695.
21. Jambo, K.C., Banda, D.H., Afran, L., Kankwatira, A.M., Malamba, R.D., Allain, T.J., Gordon, S.B., Heyderman, R.S., Russell, D.G., Mwandumba, H.C., Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria. Am. J. Respir. Crit. Care Med. 190 (2014), 938–947.
22. Khader, S.A., Bell, G.K., Pearl, J.E., Fountain, J.J., Rangel-Moreno, J., Cilley, G.E., Shen, F., Eaton, S.M., Gaffen, S.L., Swain, S.L., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007), 369–377.
23. Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31 (2013), 814–821.
24. Leeansyah, E., Ganesh, A., Quigley, M.F., Sönnerborg, A., Andersson, J., Hunt, P.W., Somsouk, M., Deeks, S.G., Martin, J.N., Moll, M., et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121 (2013), 1124–1135.
25. Lone, A.G., Atci, E., Renslow, R., Beyenal, H., Noh, S., Fransson, B., Abu-Lail, N., Park, J.J., Gang, D.R., Call, D.R., Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants. Infect. Immun. 83 (2015), 2531–2541.
26. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71 (2005), 8228–8235.
27. Lozupone, C., Cota-Gomez, A., Palmer, B.E., Linderman, D.J., Charlson, E.S., Sodergren, E., Mitreva, M., Abubucker, S., Martin, J., Yao, G., et al., Lung HIV Microbiome Project. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am. J. Respir. Crit. Care Med. 187 (2013), 1110–1117.
28. Martin, M., Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17 (2011), 10–12.
29. McDonald, D., Price, M.N., Goodrich, J., Nawrocki, E.P., DeSantis, T.Z., Probst, A., Andersen, G.L., Knight, R., Hugenholtz, P., An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6 (2012), 610–618.
30. Morris, A., Beck, J.M., Schloss, P.D., Campbell, T.B., Crothers, K., Curtis, J.L., Flores, S.C., Fontenot, A.P., Ghedin, E., Huang, L., et al., Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187 (2013), 1067–1075.
31. Parks, D.H., Tyson, G.W., Hugenholtz, P., Beiko, R.G., STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30 (2014), 3123–3124.
32. Rao, J., DiGiandomenico, A., Artamonov, M., Leitinger, N., Amin, A.R., Goldberg, J.B., Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa. Cell. Immunol. 270 (2011), 95–102.
33. Rennard, S.I., Basset, G., Lecossier, D., O'Donnell, K.M., Pinkston, P., Martin, P.G., Crystal, R.G., Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60 (1986), 532–538.
34. Schmieder, R., Edwards, R., Quality control and preprocessing of metagenomic datasets. Bioinformatics 27 (2011), 863–864.
35. Segal, L.N., Alekseyenko, A.V., Clemente, J.C., Kulkarni, R., Wu, B., Gao, Z., Chen, H., Berger, K.I., Goldring, R.M., Rom, W.N., et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome, 1, 2013, 19.
36. Segal, L.N., Clemente, J.C., Tsay, J.C., Koralov, S.B., Keller, B.C., Wu, B.G., Li, Y., Shen, N., Ghedin, E., Morris, A., et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol., 1, 2016, 16031.
37. Segal, L.N., Clemente, J.C., Wu, B.G., Wikoff, W.R., Gao, Z., Li, Y., Ko, J.P., Rom, W.N., Blaser, M.J., Weiden, M.D., Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax 72 (2017), 13–22.
38. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
39. Semple, P.L., Binder, A.B., Davids, M., Maredza, A., van Zyl-Smit, R.N., Dheda, K., Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am. J. Respir. Crit. Care Med. 187 (2013), 1249–1258.
40. Serrano-Villar, S., Vázquez-Castellanos, J.F., Vallejo, A., Latorre, A., Sainz, T., Ferrando-Martínez, S., Rojo, D., Martínez-Botas, J., Del Romero, J., Madrid, N., et al. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects. Mucosal Immunol., 2016, 10.1038/mi.2016.122 Published December 21, 2016.
41. Shenoy, M.K., Iwai, S., Lin, D.L., Worodria, W., Ayakaka, I., Byanyima, P., Kaswabuli, S., Fong, S., Stone, S., Chang, E., et al. Immune response and mortality risk relate to distinct lung microbiomes in patients with HIV and pneumonia. Am. J. Respir. Crit. Care Med. 195 (2017), 104–114.
42. Singh, P.K., Parsek, M.R., Greenberg, E.P., Welsh, M.J., A component of innate immunity prevents bacterial biofilm development. Nature 417 (2002), 552–555.
43. Stephen, T.L., Rutkowski, M.R., Allegrezza, M.J., Perales-Puchalt, A., Tesone, A.J., Svoronos, N., Nguyen, J.M., Sarmin, F., Borowsky, M.E., Tchou, J., Conejo-Garcia, J.R., Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression. Immunity 41 (2014), 427–439.
44. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20 (2014), 159–166.
45. Twigg, H.L. 3rd, Knox, K.S., Zhou, J., Crothers, K.A., Nelson, D.E., Toh, E., Day, R.B., Lin, H., Gao, X., Dong, Q., et al. Effect of advanced HIV infection on the respiratory microbiome. Am. J. Respir. Crit. Care Med. 194 (2016), 226–235.
46. Twigg Iii, H.L., Weiden, M., Valentine, F., Schnizlein-Bick, C.T., Bassett, R., Zheng, L., Wheat, J., Day, R.B., Rominger, H., Collman, R.G., et al., AIDS Clinical Trials Group Protocol 723 Team. Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J. Infect. Dis. 197 (2008), 109–116.
47. Wakabayashi, H., Yamauchi, K., Kobayashi, T., Yaeshima, T., Iwatsuki, K., Yoshie, H., Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob. Agents Chemother. 53 (2009), 3308–3316.
48. Wang, H., Geng, J., Wen, X., Bi, E., Kossenkov, A.V., Wolf, A.I., Tas, J., Choi, Y.S., Takata, H., Day, T.J., et al. The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells. Nat. Immunol. 15 (2014), 667–675.
49. Wei, H., Geng, J., Shi, B., Liu, Z., Wang, Y.H., Stevens, A.C., Sprout, S.L., Yao, M., Wang, H., Hu, H., Cutting edge: Foxp1 controls naive CD8+ T cell quiescence by simultaneously repressing key pathways in cellular metabolism and cell cycle progression. J. Immunol. 196 (2016), 3537–3541.
50. Williamson, K.S., Richards, L.A., Perez-Osorio, A.C., Pitts, B., McInnerney, K., Stewart, P.S., Franklin, M.J., Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population. J. Bacteriol. 194 (2012), 2062–2073.